+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Toxicology Drug Screening Market - Global Forecast 2026-2032- Product Image
Toxicology Drug Screening Market - Global Forecast 2026-2032- Product Image
New

Toxicology Drug Screening Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5675244
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The toxicology drug screening market is rapidly transforming as technological innovation, regulatory requirements, and evolving operational models reshape how organizations approach substance detection, confirmation, and interpretation. Senior leaders must navigate an environment where accuracy, turnaround speed, and compliance are equally critical.

Market Snapshot

The toxicology drug screening market grew from USD 34.23 billion in 2025 to USD 38.30 billion in 2026 and is projected to continue expanding at a CAGR of 14.09%, reaching USD 86.15 billion by 2032. Key drivers include the convergence of advanced instrumentation, operational synergies, and growing regulatory scrutiny. Organizations are increasingly investing in scalable solutions to meet diverse analytical demands across clinical, occupational, forensic, and home testing sectors.

Scope & Segmentation

  • Test Modalities: Includes chromatography and mass spectrometry for targeted confirmation, rapid immunoassay screening, and expanding molecular diagnostics such as PCR and next-generation sequencing.
  • Product Portfolios: Features chromatography systems, mass spectrometers, immunoassay kits, lateral flow devices, and molecular assay platforms.
  • Sample Matrices: Solutions are validated across urine, oral fluid, saliva, blood (plasma, whole blood), and hair, each offering unique detection windows and influencing testing selection.
  • Drug Targets: Encompasses amphetamines, benzodiazepines, cannabis, cocaine, opiates, and more, with differing analytical requirements.
  • Applications: Serves clinical diagnostics, forensic testing, workplace and occupational monitoring, pain management, and sports anti-doping programs.
  • End Users: Hospitals, independent laboratories, government and military facilities, home testing services, clinics, and research institutes.
  • Regions: Geographical coverage includes the Americas, Europe, Middle East & Africa, and Asia-Pacific, capturing local regulatory and procurement patterns.

Toxicology Drug Screening Market: Key Takeaways

  • Laboratories and service providers are integrating advanced analytical platforms with rapid screening to meet diverse throughput needs and regulatory demands.
  • Emerging molecular diagnostics are broadening toxicology’s reach, supporting genetic risk assessment and nontraditional sample types.
  • Service models increasingly bundle consultation, confirmation, and rapid testing, streamlining workflows and improving result interpretation across different settings.
  • Testing strategies are shaped by variations in pre-analytical protocols, sample types, and drug class, making method flexibility and validation essential.
  • Regional procurement is shaped by regulatory regimes, infrastructure readiness, and supply chain strategies, adding complexity to investment decisions for global organizations.

Tariff Impact and Supply Chain Adaptation

  • 2025 tariff measures on laboratory equipment and consumables have prompted organizations to reconsider sourcing strategies, emphasizing localized procurement and diversified supplier bases.
  • Manufacturers are focusing on regional production and aftermarket support, including remote diagnostics and maintenance, to offset cost pressures and maintain compliance.
  • Service-oriented models, such as reagent subscriptions and preventative maintenance contracts, are gaining traction as organizations seek to manage capital expenditure and operational risks.
  • Organizations balancing tight budgets are increasingly opting for outsourced confirmation services, preserving analytical quality while deferring substantial equipment investments.

Methodology & Data Sources

This report employs a robust methodology combining structured interviews with laboratory leaders, procurement managers, clinicians, and regulatory experts alongside a systematic review of technical, regulatory, and vendor literature. Triangulation of qualitative insights and platform performance data, validated by subject-matter experts, underpins the credibility and practical value of segmentation and operational findings.

Why This Report Matters

  • Empowers senior decision-makers with actionable intelligence to inform procurement, investment, and regulatory strategy in a dynamic market.
  • Delivers detailed segmentation and strategic insights relevant to laboratory operations and evolving regional landscapes.
  • Enables organizations to cultivate operational resilience and remain agile amid ongoing shifts in technology and regulation.

Conclusion

Success in toxicology drug screening depends on informed technology adoption, operational integration, and resilient procurement practices. Leaders who prioritize flexibility, workforce development, and responsive supplier relationships will be best positioned to navigate future market shifts across clinical, forensic, and workplace settings.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Toxicology Drug Screening Market, by Test Type
8.1. Chromatography And Mass Spectrometry
8.1.1. Gas Chromatography-Mass Spectrometry
8.1.2. Liquid Chromatography-Tandem Mass Spectrometry
8.2. Immunoassay
8.3. Molecular Diagnostics
8.3.1. Next-Generation Sequencing
8.3.2. PCR-Based Testing
8.4. Rapid Testing
9. Toxicology Drug Screening Market, by Product Type
9.1. Chromatography Systems
9.2. Confirmation Services
9.3. Consultation Services
9.4. Enzyme-Linked Immunosorbent Assay Kits
9.5. Lateral Flow Immunoassay Kits
9.6. Mass Spectrometers
9.7. PCR Instruments
9.8. Screening Services
10. Toxicology Drug Screening Market, by Sample Type
10.1. Blood
10.1.1. Plasma
10.1.2. Whole Blood
10.2. Hair
10.3. Oral Fluid
10.4. Saliva
10.5. Urine
11. Toxicology Drug Screening Market, by Drug Class
11.1. Amphetamines
11.2. Benzodiazepines
11.3. Cannabis
11.4. Cocaine
11.5. Opiates
12. Toxicology Drug Screening Market, by Application
12.1. Clinical Diagnostics
12.2. Forensic Testing
12.3. Pain Management
12.4. Sports Anti-Doping
12.5. Workplace Testing
13. Toxicology Drug Screening Market, by End User
13.1. Government And Military Laboratories
13.2. Home Care Testing
13.3. Hospitals And Clinics
13.4. Independent Laboratories
13.5. Research Institutes
14. Toxicology Drug Screening Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Toxicology Drug Screening Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Toxicology Drug Screening Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Toxicology Drug Screening Market
18. China Toxicology Drug Screening Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Agilent Technologies, Inc.
19.7. Alere Inc.
19.8. ARK Diagnostics, Inc.
19.9. Becton, Dickinson and Company
19.10. Bio-Rad Laboratories, Inc.
19.11. Charles River Laboratories International, Inc.
19.12. Danaher Corporation
19.13. Eurofins Scientific SE
19.14. F. Hoffmann-La Roche Ltd
19.15. Laboratory Corporation of America Holdings
19.16. Merck KGaA
19.17. Mindray Bio-Medical Electronics Co., Ltd.
19.18. OraSure Technologies, Inc.
19.19. Ortho Clinical Diagnostics
19.20. PerkinElmer, Inc.
19.21. Quest Diagnostics Incorporated
19.22. Shimadzu Corporation
19.23. Siemens Healthineers AG
19.24. Sysmex Corporation
19.25. Thermo Fisher Scientific Inc.
19.26. Waters Corporation
List of Figures
FIGURE 1. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR-BASED TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR-BASED TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RAPID TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RAPID TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RAPID TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONFIRMATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONFIRMATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONFIRMATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONSULTATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONSULTATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONSULTATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MASS SPECTROMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MASS SPECTROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SCREENING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SCREENING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HAIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HAIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HAIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ORAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ORAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY AMPHETAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY AMPHETAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BENZODIAZEPINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BENZODIAZEPINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CANNABIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CANNABIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CANNABIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COCAINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COCAINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COCAINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY OPIATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY OPIATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY OPIATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY FORENSIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY FORENSIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SPORTS ANTI-DOPING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SPORTS ANTI-DOPING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SPORTS ANTI-DOPING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WORKPLACE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WORKPLACE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WORKPLACE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GOVERNMENT AND MILITARY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GOVERNMENT AND MILITARY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GOVERNMENT AND MILITARY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOME CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOME CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 173. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 188. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 189. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 190. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 193. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 194. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 209. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 210. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 211. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 214. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 215. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. ASEAN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 219. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 220. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 221. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 223. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 224. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 225. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. GCC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 239. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 240. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 241. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 243. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 244. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 245. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. BRICS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 249. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 250. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 251. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 252. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 253. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 254. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 255. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. G7 TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 259. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 260. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 261. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 263. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 264. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 265. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. NATO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 279. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 280. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 281. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 282. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 283. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 284. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 285. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 286. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. CHINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Toxicology Drug Screening market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alere Inc.
  • ARK Diagnostics, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Mindray Bio-Medical Electronics Co., Ltd.
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 38.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 86.15 Billion
Compound Annual Growth Rate14.0%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Drug Screening Market - Global Forecast 2026-2032 - Product Image

Drug Screening Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Neonatal Toxicology - Global Strategic Business Report - Product Image

Neonatal Toxicology - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
Toxicology Drug Screening Global Market Report 2025 - Product Image

Toxicology Drug Screening Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
ADME Toxicology Testing Market Report 2025 - Product Image

ADME Toxicology Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Neonatal Toxicology Market Size, Share & Trends Analysis Report by Specimen (Urine, Umbilical Cord, Meconium), Technology (Mass spectroscopy, Immunoassay), Drug (Cannabinoids, Opioids), End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Neonatal Toxicology Market Size, Share & Trends Analysis Report by Specimen (Urine, Umbilical Cord, Meconium), Technology (Mass spectroscopy, Immunoassay), Drug (Cannabinoids, Opioids), End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From

About the Market

The Toxicology Test market within the context of Diagnostics is a specialized field of testing that focuses on the detection of toxic substances in the body. It is used to identify the presence of drugs, alcohol, and other hazardous substances in the body. Toxicology tests are used to detect the presence of drugs in the body, to monitor drug levels in the body, and to assess the effects of drugs on the body. Toxicology tests are also used to detect the presence of hazardous substances in the environment, such as heavy metals, pesticides, and other pollutants. The Toxicology Test market is a rapidly growing field, with new technologies and methods being developed to improve accuracy and efficiency. Toxicology tests are used in a variety of settings, including clinical laboratories, research laboratories, and public health laboratories. Some companies in the Toxicology Test market include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.